BIMI Medical Stock (NASDAQ:BIMI)


RevenueOwnershipFinancialsChart

Previous Close

$NaN

52W Range

$0.01 - $4.13

50D Avg

$0.17

200D Avg

$1.49

Market Cap

$139.61K

Avg Vol (3M)

$386.78K

Beta

1.70

Div Yield

-

BIMI Company Profile


BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.

Show More

Industry

Medical - Pharmaceuticals

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CN

Employees

296

IPO Date

Oct 18, 2006

Website

BIMI Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 21Dec 20
OthersMember$14.16K-
DrugsWholesaleMember$16.91M$9.70M
MedicalServicesMember$6.40M-
RetailPharmacyMember$316.65K$84.09K
MedicalDeviceWholesaleMember$3.45M$3.06M

Fiscal year ends in Dec 22 | Currency in USD

BIMI Financial Summary


Dec 22Dec 21Dec 20
Revenue$11.83M$27.08M$12.84M
Operating Income$-9.95M$-8.11M$-3.81M
Net Income$-21.63M$-34.92M$-3.79M
EBITDA$-12.58M$-8.20M$-3.76M
Basic EPS$-8.12$-3.26K$-17.74
Diluted EPS$-8.12$-3.26K$-17.74

Fiscal year ends in Dec 22 | Currency in USD

Peer Comparison


TickerCompany
MDVLMedAvail Holdings, Inc.
PETSPetMed Express, Inc.
LFLYLeafly Holdings, Inc.
CJJDChina Jo-Jo Drugstores, Inc.
RADRite Aid Corporation
MEDSTRxADE HEALTH, Inc.